Cyst Fluid Biosignature to Predict Intraductal Papillary Mucinous Neoplasms of the Pancreas with High Malignant Potential

BACKGROUND: Current standard-of-care technologies such as imaging and cyst fluid analysis are unable to consistently distinguish intraductal papillary mucinous neoplasms of the pancreas (IPMN) at high-risk of pancreatic cancer from low-risk IPMN. The objective was to create a single-platform assay t...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Am Coll Surg
Päätekijät: Maker, Ajay V, Hu, Vincent, Kadkol, Shrihari S, Hong, Lenny, Brugge, William, Winter, Jordan, Yeo, Charles J, Hackert, Thilo, Buchler, Marcus, Lawlor, Rita T, Salvia, Roberto, Scarpa, Aldo, Bassi, Claudio, Green, Stefan
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2019
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6487216/
https://ncbi.nlm.nih.gov/pubmed/30794864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jamcollsurg.2019.02.040
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia